Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor

Abstract

Purpose: Tumor necrosis factor α (TNF-α) has been shown to play a role in pulmonary injury after lower-extremity ischemia/reperfusion (I/R). However, its role in direct skeletal muscle injury is poorly understood. The hypothesis that endogenous TNF production contributes to skeletal muscle injury after hindlimb I/R in rats was tested. Methods: Juvenile male Sprague-Dawley rats underwent 4 hours of bilateral hindlimb ischemia and 4 hours of reperfusion (IR) or sham operation (SHAM). A subset was treated with a soluble TNF receptor I construct (STNFRI, 10 mg/kg) 1 hour before ischemia (PRE) or at reperfusion (POST). Direct skeletal muscle injury (SMII) and muscle endothelial capillary permeability (MPI) were quantified by means of Tc 99 pyrophosphate and I 125 albumin uptake. Pulmonary neutrophil infiltration and hepatocellular injury were assessed by means of myeloperoxidase content (MPO) and aspartate aminotransferase (AST) concentrations, respectively. Serum TNF bioactivity was measured with the WEHI bioassay. Results: Hindlimb I/R (IR vs SHAM) resulted in a significant ( P < .05) increase in the SMII (0.52 ± 0.06 vs 0.07 ± 0.01) and MPI (0.35 ± .04 vs 0.06 ± 0.01). Pretreatment with STNFRI (PRE vs IR) significantly ameliorated both SMII (0.30 ± 0.05 vs 0.52 ± 0.06) and MPI (0.23 ± 0.02 vs 0.35 ± 0.04), whereas treatment at reperfusion (POST vs IR) had no effect. Hindlimb I/R (IR vs SHAM) resulted in both significant pulmonary neutrophil infiltration (MPO 16.4 ± 1.06 U/g vs 11.3 ± 1.4 U/g) and hepatocellular injury (AST 286 ± 45 U/mL vs 108 ± 30 U/mL), but neither was inhibited by pretreatment with STNFRI before ischemia. Detectable levels of TNF were measured during ischemia in a significantly higher percentage of the IR group compared with SHAM (9 of 12 vs 3 of 12), and the maximal TNF values were also significantly greater (51.1 ± 12.6 pg/mL vs 5.5 ± 2.9 pg/mL). No TNF was detected in any treatment group during reperfusion nor after administration of the STNFRI. Conclusion: Acute hindlimb IR initiates a systemic TNF response during the ischemic period that is partly responsible for the associated skeletal muscle injury. (J Vasc Surg 1999;29:370-6.)